Our Privacy Statement & Cookie Policy
We use cookies to personalize content and ads, to provide features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. Privacy Policy

Skip to content

The Daily NewsBrief

The Daily NewsBrief

Vaccines

Pfizer, Valneva Launch Major Trial to Test Lyme Disease Vaccine

August 9, 2022

Pfizer and French partner Valneva have launched a late-stage clinical trial of an experimental vaccine aimed to protect against Lyme disease. In a joint statement on Aug. 8, the biotech … Read more

Media Topic: Tags Biomedical science Biotechnology Diseases and conditions Health Vaccines

New Zealand Unsure of Monkeypox Vaccine Arrival

August 4, 2022

New Zealand health officials said Thursday there is no guaranteed monkeypox vaccine supply yet for the country because of global demands. Te Whatu Ora-Health New Zealand national director Dr. Nick … Read more

Media Topic: Tags Communicable disease Government health care Vaccines Virus disease

New Zealand Unsure of Monkeypox Vaccine Arrival

August 4, 2022

New Zealand health officials said Thursday there is no guaranteed monkeypox vaccine supply yet for the country because of global demands. Te Whatu Ora-Health New Zealand national director Dr. Nick … Read more

Media Topic: Tags Communicable disease Government health care Vaccines Virus disease

Study Suggests Fourth Pfizer Dose Reduced Risk of Catching Omicron COVID-19

August 3, 2022

A study conducted by the Tel Aviv University in Israel revealed that a fourth Pfizer vaccine dose reduces the risk of catching the Omicron variant of COVID-19. The study, published … Read more

Media Topic: Tags Communicable disease Health Vaccines

Singapore Approves AstraZeneca’s COVID-19 Antibody Jab for Adults Medically Unsuitable for Vaccination

August 1, 2022

The Health Sciences Authority (HSA), a statutory board under the Ministry of Health of the Government of Singapore, granted an interim authorization under the Pandemic Special Access Route (PSAR) for … Read more

Media Topic: Tags Health Pandemic Vaccines Virus disease

Singapore Approves AstraZeneca’s COVID-19 Antibody Jab for Adults Medically Unsuitable for Vaccination

August 1, 2022

The Health Sciences Authority (HSA), a statutory board under the Ministry of Health of the Government of Singapore, granted an interim authorization under the Pandemic Special Access Route (PSAR) for … Read more

Media Topic: Tags Health Pandemic Vaccines Virus disease

EU OKs Smallpox Vaccine For Use Against Monkeypox

July 27, 2022

The European Medicines Agency (EMA) has approved using smallpox vaccines to fight and prevent monkeypox virus infections. Biotechnology company Bavarian Nordic said Wednesday that EMA approved the manufacture and marketing … Read more

Media Topic: Tags Biotechnology Communicable disease Health organizations Vaccines Virus disease

Uganda Parliament Rejects Mandatory Adult Vaccination Law

July 21, 2022

A proposed new law to make vaccines compulsory adults in the event of a disease outbreak has been voted down by Uganda’s parliament. Uganda’s health ministry said the proposed legislation … Read more

Media Topic: Tags Health Safety of citizens Vaccines

U.S. CDC Recommends Novavax COVID-19 Vaccine for Adults

July 20, 2022

The United States Centers for Disease Control and Prevention (CDC) recommended the Novavax COVID-19 vaccine as a two-dose primary series in adults. CDC Director Rochelle Walensky endorsed the recommendation of … Read more

Media Topic: Tags Health Health organizations Vaccines Virus disease

U.S. FDA Authorizes Novavax’s COVID-19 Vaccine for Emergency Use

July 13, 2022

The United States Food and Drug Administration (FDA) authorized Novavax’s COVID-19 vaccine for emergency use for adults on July 13. The Novavax vaccine is administered as a two-dose primary series, … Read more

Media Topic: Tags Health Pandemic Vaccines
Post navigation
Older posts
Page1 Page2 … Page48 Next →
+ MORE NEWS BULLETINS
NEWS | WEATHER | MARKETS | CRYPTO | COVID-19 | TRENDING

© 2022 - Fourth Estate®
About | Terms | Privacy | NewsCERT™ | RSS Feed
Next Page »
  • THE DAILY NEWSBRIEF
  • SUBSCRIBE
  • SIGN IN
en English
af Afrikaanssq Shqipam አማርኛar العربيةhy Հայերենaz Azərbaycan dilieu Euskarabe Беларуская моваbn বাংলাbs Bosanskibg Българскиca Catalàceb Cebuanony Chichewazh-CN 简体中文zh-TW 繁體中文co Corsuhr Hrvatskics Čeština‎da Dansknl Nederlandsen Englisheo Esperantoet Eestitl Filipinofi Suomifr Françaisfy Fryskgl Galegoka ქართულიde Deutschel Ελληνικάgu ગુજરાતીht Kreyol ayisyenha Harshen Hausahaw Ōlelo Hawaiʻiiw עִבְרִיתhi हिन्दीhmn Hmonghu Magyaris Íslenskaig Igboid Bahasa Indonesiaga Gaeilgeit Italianoja 日本語jw Basa Jawakn ಕನ್ನಡkk Қазақ тіліkm ភាសាខ្មែរko 한국어ku كوردی‎ky Кыргызчаlo ພາສາລາວla Latinlv Latviešu valodalt Lietuvių kalbalb Lëtzebuergeschmk Македонски јазикmg Malagasyms Bahasa Melayuml മലയാളംmt Maltesemi Te Reo Māorimr मराठीmn Монголmy ဗမာစာne नेपालीno Norsk bokmålps پښتوfa فارسیpl Polskipt Portuguêspa ਪੰਜਾਬੀro Românăru Русскийsm Samoangd Gàidhligsr Српски језикst Sesothosn Shonasd سنڌيsi සිංහලsk Slovenčinasl Slovenščinaso Afsoomaalies Españolsu Basa Sundasw Kiswahilisv Svenskatg Тоҷикӣta தமிழ்te తెలుగుth ไทยtr Türkçeuk Українськаur اردوuz O‘zbekchavi Tiếng Việtcy Cymraegxh isiXhosayi יידישyo Yorùbázu Zulu
Fourth Estate®